Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B5513 JNJ 5207852 dihydrochlorideSummary: histamine H3 receptor neutral antagonist
- B5532 NPS 2390Target: Glutamate (Metabotropic) Group I ReceptorsSummary: group I mGlu antagonist
- B5538 WY 45233 succinateSummary: serotonin and noradrenalin reuptake inhibitor
- B5555 VU 0360172 hydrochlorideSummary: positive allosteric modulator of mGlu5 receptors
- B5560 Ro 67-7476Summary: positive allosteric modulator of mGlu1 receptors
- B5565 TC-N 22ASummary: mGlu4 receptor positive allosteric modulator
- B5569 VU 0285683Summary: negative allosteric modulator of mGlu5 receptors
- B5571 MNI 137Summary: negative allosteric modulator of group II mGlu receptors
- B5574 VU 0360223Summary: negative allosteric modulator of mGlu5
- B5579 VU 0365114Summary: positive allosteric modulator of M5